Approvals/TGA/IIRINOTECAN APOTEX irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection via

Approved

STANDARD

IIRINOTECAN APOTEX irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection via

Baxter Healthcare Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: f7d97c5fcc8d771a
Product Name: IIRINOTECAN APOTEX irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection via
Artg Id: 246740
Artg Name: IRINOTECAN APOTEX irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial
Sponsor: Baxter Healthcare Pty Ltd
Company Detail Path: /organization/baxter-healthcare-pty-ltd
Artg Date: 2016-05-23
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

f7d97c5fcc8d771a

Type

Standard